Therefore, this confirmed that FoxA3 has oncogenic functions via the inductions of proliferation and invasion of the cancer cells lead to intrahepatic CCA progression with aggressive clinical outcomes such as high metastasis. Here, FOXA3 is linked to cholangiocarcinoma.